Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Jun-24 4:22 PM View:  | Cara Therapeutics, Inc. (CARA) | 04-Jun-24 | Grant | 301,295 | -- | -- | 275% 109.71K to 411.01K | |
| 05-Jun-23 4:29 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-23 | Grant | 64,724 | -- | -- | 144% 44.99K to 109.71K | |
| 16-Sep-22 4:21 PM View: | Cara Therapeutics, Inc. (CARA) | 14-Sep-22 | Sale | 10,800 | $10.28 | $111,024.00 | (19%) 55.79K to 44.99K | |
| 06-Jun-22 5:49 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jun-22 | Grant | 35,628 | -- | -- | 177% 20.16K to 55.79K | |
| 07-Jun-21 7:35 PM View: | Cara Therapeutics, Inc. (CARA) | 07-Jun-21 | Market Sale (Planned) | 8,640 | $13.05 | $112,752.00 | (30%) 28.8K to 20.16K | |
| 07-Jun-21 7:35 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Jun-21 | Grant | 14,400 | -- | -- | 100% 14.4K to 28.8K | |
| 19-Nov-20 5:30 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Nov-20 | Market Sale | 6,000 | $16.09 | $96,540.00 | (29%) 20.4K to 14.4K | 2% |
| 08-Jun-20 5:49 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-20 | Grant | 14,400 | -- | -- | 240% 6.0K to 20.4K | |
| 06-Jun-19 6:04 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-19 | Grant | 6,000 | -- | -- | < 1% 3.07M to 3.07M | |
| 18-Mar-16 7:43 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Mar-16 | Market Purchase Duplicate | 247,727 | $4.93 | $1,221,370.00 | 9% 2.82M to 3.07M | 182% |
| 18-Mar-16 7:43 PM View: | Cara Therapeutics, Inc. (CARA) | 16-Mar-16 | Market Purchase Duplicate | 152,273 | $4.78 | $727,834.00 | 6% 2.67M to 2.82M | 191% |
| 19-Feb-14 4:18 PM View: | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Grant | 180,997 | -- | -- | 9% 2.09M to 2.27M | |
| 19-Feb-14 4:18 PM View: | Nephrogenex, Inc. (NRX) | 14-Feb-14 | Conversion | 1,145,830 | -- | -- | 50% 2.27M to 3.42M | |
| 05-Feb-14 5:17 PM View: | Cara Therapeutics, Inc. (CARA) | 05-Feb-14 | Conversion Duplicate | 2,442,240 | -- | -- | 100% 0 to 2.44M | |
| 05-Feb-14 5:17 PM View: | Cara Therapeutics, Inc. (CARA) | 05-Feb-14 | Purchase Duplicate | 225,818 | $11.00 | $2,484,000.00 | 9% 2.44M to 2.67M |